Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Delivra Health Brands ( (TSE:DHB) ) is now available.
Delivra Health Brands reported an 8% increase in net revenue for fiscal 2025, driven by double-digit growth in its Dream Water® and LivRelief™ brands across e-commerce and retail channels. Despite a decline in revenue from its LivRelief™ Infused business, the company is revising its market strategy to leverage consumer demand. The company also experienced increased gross profit and higher sales activity, although adjusted EBITDA declined due to investments in marketing and innovation. Delivra Health is optimistic about future growth, supported by strong retail partnerships and a pipeline of new products.
The most recent analyst rating on (TSE:DHB) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Delivra Health Brands stock, see the TSE:DHB Stock Forecast page.
Spark’s Take on TSE:DHB Stock
According to Spark, TipRanks’ AI Analyst, TSE:DHB is a Neutral.
Delivra Health Brands is in a recovery phase with improving financial metrics and strategic corporate actions. However, the poor valuation due to negative earnings and lack of dividends weigh heavily on the score. The technical analysis suggests neutral market sentiment, and corporate events are positive, indicating potential for future growth.
To see Spark’s full report on TSE:DHB stock, click here.
More about Delivra Health Brands
Delivra Health Brands Inc. is a consumer packaged goods company operating in the health and wellness sector. It offers innovative brands such as Dream Water® and LivRelief™, which provide solutions for common health issues like sleeplessness, chronic pain, and anxiety.
Average Trading Volume: 17,069
Technical Sentiment Signal: Buy
Current Market Cap: C$10.94M
Learn more about DHB stock on TipRanks’ Stock Analysis page.